Generic Name and Formulations:
Eflornithine HCl 13.9%; crm.
Indications for VANIQA:
Reduction of unwanted facial hair in women.
Apply a thin layer to affected areas of face and adjacent areas under the chin twice daily at least 8 hours apart; rub in thoroughly. Do not wash treated area for at least 4 hours. Continue to use hair removal techniques as needed. May apply cosmetics or sunscreens after cream dries.
Reduce frequency if irritation or intolerance develops; discontinue if irritation continues. Abraded or broken skin. Pregnancy (Cat.C): not recommended. Nursing mothers.
Hair growth retardant.
Acne, pseudofolliculitis barbae, stinging, headache, burning, dry skin, erythema, tingling, dyspepsia, irritation, rash, alopecia, dizziness.
Crm—30g, 60g (2x30g)
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)